| RS2142851443 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142851672 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS2142851681 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS2142851880 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142852868 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142852888 |
MYBPC3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2142852944 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142853009 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142853029 |
MYBPC3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2142853045 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142855105 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy 4 |
| RS2142855351 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142856521 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS2142856547 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS2142856590 |
MYBPC3
|
Health Risk |
Pathogenic |
— |
| RS2142856598 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS2142856729 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy 4, Hypertrophic cardiomyopathy |
| RS2142857246 |
TUBGCP4
|
Health Risk |
Likely pathogenic |
— |
| RS2142857362 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142857371 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS2142859053 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Hypertrophic cardiomyopathy 4 |
| RS2142859071 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142859074 |
MYBPC3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hypertrophic cardiomyopathy |
| RS2142859289 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142859359 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142859427 |
MYBPC3
|
Health Risk |
Likely pathogenic |
— |
| RS2142860329 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy 4, Hypertrophic cardiomyopathy 4 |
| RS2142860830 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy 4, Hypertrophic cardiomyopathy |
| RS2142860924 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142861049 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy 4, Hypertrophic cardiomyopathy 4 |
| RS2142861091 |
MYBPC3
|
Health Risk |
Pathogenic |
— |
| RS2142861325 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142861454 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142861512 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142861729 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS2142861940 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142862199 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142862326 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS2142862333 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS2142864164 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS2142864321 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS2142864883 |
PIGL
|
Health Risk |
Likely pathogenic |
CHIME syndrome, CHIME syndrome |
| RS2142865197 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142865199 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142865236 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS2142865708 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 4, Hypertrophic cardiomyopathy 4 |
| RS2142865711 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hypertrophic cardiomyopathy |
| RS2142866256 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142866326 |
MYBPC3
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Cardiovascular phenotype |
| RS2142866705 |
CTCF
|
Health Risk |
Pathogenic |
— |
| RS2142867623 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142867765 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS2142867804 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142867855 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142868665 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142868691 |
MYBPC3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Cardiomyopathy |
| RS2142868794 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142869314 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS2142869406 |
MYBPC3
|
Health Risk |
Likely pathogenic |
Cardiomyopathy, Cardiomyopathy |
| RS2142869736 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS2142869764 |
CYBA
|
Health Risk |
Conflicting classifications of pathogenicity |
Granulomatous disease, chronic |
| RS2142869802 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy 4, Hypertrophic cardiomyopathy 4 |
| RS2142873834 |
CYBA
|
Health Risk |
Likely pathogenic |
Granulomatous disease, chronic |
| RS2142875237 |
CYBA
|
Health Risk |
Likely pathogenic |
Granulomatous disease, chronic |
| RS2142877263 |
CYBA
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2142881946 |
DLG4
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2142883490 |
CYBA
|
Health Risk |
Pathogenic |
Granulomatous disease, chronic |
| RS2142883686 |
TUBGCP4
|
Health Risk |
Pathogenic |
— |
| RS2142883774 |
DLG4
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2142883806 |
TUBGCP4
|
Health Risk |
Pathogenic |
— |
| RS2142884288 |
DLG4
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2142884393 |
SPI1
|
Health Risk |
Pathogenic |
PU.1-mutated agammaglobulinemia, Agammaglobulinemia 10 |
| RS2142884433 |
DLG4
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2142885279 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2142885581 |
DLG4
|
Health Risk |
Pathogenic |
— |
| RS2142885592 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2142885916 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2142886433 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2142886600 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2142886687 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2142886707 |
DLG4
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS2142887156 |
CTCF
|
Health Risk |
Likely pathogenic |
CTCF-related neurodevelopmental disorder, CTCF-related neurodevelopmental disorder |
| RS2142888007 |
DLG4
|
Health Risk |
Pathogenic |
Intellectual developmental disorder 62, Inborn genetic diseases |
| RS2142896426 |
MVD
|
Health Risk |
Likely pathogenic |
Linear porokeratosis, Linear porokeratosis |
| RS2142896446 |
TUBGCP4
|
Health Risk |
Pathogenic |
— |
| RS2142896980 |
TUBGCP4
|
Health Risk |
Likely pathogenic |
— |
| RS2142904095 |
IGHM
|
Health Risk |
Likely pathogenic |
Autosomal recessive agammaglobulinemia 1, Autosomal recessive agammaglobulinemia 1 |
| RS2142904392 |
IGHM
|
Health Risk |
Pathogenic |
Autosomal recessive agammaglobulinemia 1, Autosomal recessive agammaglobulinemia 1 |
| RS2142906391 |
MVD
|
Health Risk |
Pathogenic |
Porokeratosis 7, multiple types |
| RS2142909461 |
CARMIL2
|
Health Risk |
Likely pathogenic |
— |
| RS2142909875 |
CARMIL2
|
Health Risk |
Pathogenic |
— |
| RS2142916354 |
CARMIL2
|
Health Risk |
Pathogenic |
— |
| RS2142927120 |
CARMIL2
|
Health Risk |
Likely pathogenic |
— |
| RS2142945856 |
CDT1
|
Health Risk |
Pathogenic |
Meier-Gorlin syndrome 4, Meier-Gorlin syndrome 4 |
| RS2142947295 |
ABAT
|
Health Risk |
Likely pathogenic |
Gamma-aminobutyric acid transaminase deficiency, Gamma-aminobutyric acid transaminase deficiency |
| RS2142950251 |
CARMIL2
|
Health Risk |
Pathogenic |
— |
| RS2142950877 |
APRT
|
Health Risk |
Likely pathogenic |
— |
| RS2142952273 |
APRT
|
Health Risk |
Pathogenic |
— |
| RS2142952361 |
APRT
|
Health Risk |
Pathogenic |
— |
| RS2142959784 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |